Vir Biotechnology (VIR) Non-Current Deffered Revenue (2018 - 2025)
Vir Biotechnology (VIR) posted Non-Current Deffered Revenue of $9.43 million for Q3 2025.
Powered by 
Analysis
Vir Biotechnology (VIR) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends
At the end of FY2023, Vir Biotechnology's Non-Current Deffered Revenue came in at $1.53 million, down 97.1% from FY2022.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -25.3% (FY2018 to FY2023).
- In prior years, Vir Biotechnology's Non-Current Deffered Revenue was $53.21 million in FY2022, $3.82 million in FY2021 (unchanged), $3.82 million in FY2020 (-69.9%) and $12.67 million in FY2019 (+93.1%).
- The Q3 2025 figure stands as the highest quarterly Non-Current Deffered Revenue since Q3 2023.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q1 2023, with growth of 807.2%; the weakest was Q4 2023, with a decline of 97.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 9.43 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 53.21 Mn |
| Jun 30, 2023 | 53.21 Mn |
| Mar 31, 2023 | 53.21 Mn |
| Dec 31, 2022 | 53.21 Mn |
| Sep 30, 2022 | 54.65 Mn |
| Jun 30, 2022 | 4.42 Mn |
| Mar 31, 2022 | 5.87 Mn |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | 3.82 Mn |
| Jun 30, 2021 | 55.50 Mn |
| Mar 31, 2021 | 3.82 Mn |
| Dec 31, 2020 | 3.82 Mn |
| Sep 30, 2020 | 3.82 Mn |
| Jun 30, 2020 | 3.82 Mn |
| Mar 31, 2020 | 6.56 Mn |
| Dec 31, 2019 | 12.67 Mn |
| Sep 30, 2019 | 8.41 Mn |
API Access
Vir Biotechnology Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();